Brain Aggregates: An EffectiveIn VitroCell Culture System Modeling Neurodegenerative Diseases
Authors:
- 5 February 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 75 (3) , 256-262
Abstract
Drug discovery for neurodegenerative diseases is particularly challenging because of the discrepancies in drug effects between in vitro and in vivo studies. These discrepancies occur in part because current cell culture systems used for drug screening have many limitations. First, few cell culture systems accurately model human aging or neurodegenerative diseases. Second, drug efficacy may differ between dividing and stationary cells, the latter resembling nondividing neurons in the CNS. Brain aggregates (BrnAggs) derived from embryonic day 15 gestation mouse embryos may represent neuropathogenic processes in prion disease and reflect in vivo drug efficacy. Here, we report a new method for the production of BrnAggs suitable for drug screening and suggest that BrnAggs can model additional neurological diseases such as tauopathies. We also report a functional assay with BrnAggs by measuring electrophysiological activities. Our data suggest that BrnAggs could serve as an effective in vitro cell culture system for drug discovery for neurodegenerative diseases.Keywords
Funding Information
- National Institutes of Health (K01AG039386, R21AG044720)
- National Institute on Aging
This publication has 22 references indexed in Scilit:
- A three-dimensional human neural cell culture model of Alzheimer’s diseaseNature, 2014
- A High-Throughput Screening Assay for Determining Cellular Levels of Total Tau ProteinCurrent Alzheimer Research, 2013
- A Brain Aggregate Model Gives New Insights Into the Pathobiology and Treatment of Prion DiseasesJournal of Neuropathology & Experimental Neurology, 2012
- Testing neocortical slice viability in non-perfused no-magnesium artificial cerebrospinal fluid solutionsJournal of Neuroscience Methods, 2012
- Investigating paradoxical hysteresis effects in the mouse neocortical slice modelEuropean Journal of Pharmacology, 2012
- Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's DiseasePLOS ONE, 2011
- Drug discovery in Parkinson's disease: update and developments in the use of cellular modelsInternational Journal of High Throughput Screening, 2011
- Continuous Quinacrine Treatment Results in the Formation of Drug-Resistant PrionsPLOS Pathogens, 2009
- A γ-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brainsProceedings of the National Academy of Sciences, 2008
- Mice devoid of PrP are resistant to scrapieCell, 1993